Cocrystal Pharma, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the results of the 2026 Annual Meeting of Stockholders held on July 14, 2026. Cocrystal Pharma, Inc. is a Delaware corporation with its principal executive offices in Bothell, WA, and its common stock trades on The Nasdaq Capital Market under the symbol COCP.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders voted on three proposals at the Annual Meeting. Proposals 1 and 2 were approved, rendering Proposal 3 moot.
- Proposal 1 (Election of Directors): All five nominees were elected to the Board of Directors.
- Proposal 2 (Ratification of Auditors): Stockholders ratified the appointment of Weinberg & Company as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Proposal 3 (Adjournment): This proposal was not voted upon as sufficient votes were received for the other proposals.
| Nominee | Votes For | Abstentions | Broker Non-Votes |
|---|---|---|---|
| Dr. Roger Kornberg | 6,113,868 | 392,124 | 2,860,552 |
| Dr. Phillip Frost | 6,276,012 | 229,980 | 2,860,552 |
| Mr. Fred Hassan | 6,293,331 | 212,661 | 2,860,552 |
| Mr. Richard C. Pfenniger, Jr. | 5,964,606 | 541,386 | 2,860,552 |
| Mr. Steven Rubin | 5,914,522 | 591,470 | 2,860,552 |
Proposal 2 Voting Breakdown: 9,181,034 votes For, 174,923 votes Against, and 10,587 Abstentions.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management commentary on future outlook, specific risks, contingencies, or unusual items. The document is limited to reporting the outcome of the shareholder vote.
Key Facts for Investor Verification
- Verify the composition of the newly elected Board of Directors against the company's latest proxy statement.
- Confirm the engagement of Weinberg & Company as the independent auditor for the 2026 fiscal year.
- Note the significant number of Broker Non-Votes (2,860,552) recorded for the director elections, which may indicate shares held in street name where brokers lacked discretionary voting power.
- Review the definitive proxy statement filed on May 27, 2026, for detailed biographies of directors and the rationale for auditor selection.